Pharmaron Beijing Co., Ltd. (SHE:300759)
China flag China · Delayed Price · Currency is CNY
31.32
-0.02 (-0.06%)
Sep 2, 2025, 2:45 PM CST

Pharmaron Beijing Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 2016 - 2020
Operating Revenue
13,10112,26911,53310,2407,4195,114
Upgrade
Other Revenue
11.326.44.6126.1924.4819.55
Upgrade
13,11212,27611,53810,2667,4445,134
Upgrade
Revenue Growth (YoY)
14.00%6.39%12.39%37.92%45.00%36.63%
Upgrade
Cost of Revenue
8,6128,0917,4226,5024,7683,215
Upgrade
Gross Profit
4,5004,1844,1163,7642,6761,919
Upgrade
Selling, General & Admin
1,8651,8431,8591,7281,022745.89
Upgrade
Research & Development
511.92469.26448.28282.32151.77105.35
Upgrade
Other Operating Expenses
135.48109.782.7566.5244.0432.9
Upgrade
Operating Expenses
2,5692,4652,4262,0981,229898.95
Upgrade
Operating Income
1,9311,7191,6901,6671,4481,020
Upgrade
Interest Expense
-251.45-243.72-182.19-167.31-83.07-23.85
Upgrade
Interest & Investment Income
-615.778.95109.74371.99231.55
Upgrade
Currency Exchange Gain (Loss)
-23.4731.43147-42.39-3.16-131.23
Upgrade
Other Non Operating Income (Expenses)
-3.61-4.22-3.61-2.54-1.39-1.35
Upgrade
EBT Excluding Unusual Items
1,6522,1181,7301,5641,7321,095
Upgrade
Impairment of Goodwill
-73.54-73.54----
Upgrade
Gain (Loss) on Sale of Investments
7.321.5418.7568.09119.59190.86
Upgrade
Gain (Loss) on Sale of Assets
-24.44-33.67-9.15-15.3-4.25-7.28
Upgrade
Other Unusual Items
115.4578.5198.4849.563.7340.72
Upgrade
Pretax Income
1,6772,0911,8381,6661,9111,319
Upgrade
Income Tax Expense
393.33377.1256.11314.25290.92172.38
Upgrade
Earnings From Continuing Operations
1,2841,7141,5821,3521,6201,147
Upgrade
Minority Interest in Earnings
97.579.1919.3222.4740.9525.39
Upgrade
Net Income
1,3811,7931,6011,3751,6611,172
Upgrade
Net Income to Common
1,3811,7931,6011,3751,6611,172
Upgrade
Net Income Growth
-28.37%12.01%16.48%-17.24%41.68%114.25%
Upgrade
Shares Outstanding (Basic)
1,7641,7701,7721,7741,7811,779
Upgrade
Shares Outstanding (Diluted)
1,7671,7731,7751,7761,8201,785
Upgrade
Shares Change (YoY)
-0.55%-0.11%-0.05%-2.40%1.97%20.06%
Upgrade
EPS (Basic)
0.781.010.900.780.930.66
Upgrade
EPS (Diluted)
0.781.010.900.770.910.66
Upgrade
EPS Growth
-27.97%12.13%16.54%-15.21%38.94%78.46%
Upgrade
Free Cash Flow
640.62536.02-111.78-807.04-34.78332.77
Upgrade
Free Cash Flow Per Share
0.360.30-0.06-0.45-0.020.19
Upgrade
Dividend Per Share
0.2000.2000.2000.2000.2000.133
Upgrade
Dividend Growth
----50.04%99.85%
Upgrade
Gross Margin
34.32%34.09%35.67%36.67%35.95%37.38%
Upgrade
Operating Margin
14.73%14.01%14.64%16.23%19.45%19.87%
Upgrade
Profit Margin
10.54%14.61%13.88%13.39%22.31%22.84%
Upgrade
Free Cash Flow Margin
4.89%4.37%-0.97%-7.86%-0.47%6.48%
Upgrade
EBITDA
2,8582,5832,4312,2271,8521,325
Upgrade
EBITDA Margin
21.79%21.04%21.07%21.70%24.88%25.81%
Upgrade
D&A For EBITDA
926.64863.3741.2560.76404.64304.85
Upgrade
EBIT
1,9311,7191,6901,6671,4481,020
Upgrade
EBIT Margin
14.73%14.01%14.64%16.23%19.45%19.87%
Upgrade
Effective Tax Rate
23.45%18.03%13.94%18.86%15.22%13.06%
Upgrade
Revenue as Reported
13,11212,27611,53810,2667,4445,134
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.